Studies on bioequivalence of two nimodipine capsules in healthy volunteers
Zou Jian
Abstract
Zou Jian
Abstract
[Objective]To evaluate the bioequivalence of two domestic Flunarizine capsules. A single oral administration of 20 mg Flunarizine capsule was given to 20 healthy volunteers. Flunarizine concentrations in plasma were determined by HPLC-MS. The main pharmacokinetic parameters of two domestic Flunarizine capsules were as follow: t1/2 (2.43±0.56), (2.38±0.43) h, tmax(2.67±0.82), (2.74±0.80) h, cmax (63.37±15.36), (64.07±14.43) ng/mL,AUC (130.36±15.20), (128.47±20.87) ng/(h·mL) respectively. The relative bioavailability of the test capsule was (101.5±6.3)%. [Conclusion] The results demonstrate that the two capsules are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]To evaluate the bioequivalence of two domestic Flunarizine capsules. A single oral administration of 20 mg Flunarizine capsule was given to 20 healthy volunteers. Flunarizine concentrations in plasma were determined by HPLC-MS. The main pharmacokinetic parameters of two domestic Flunarizine capsules were as follow: t1/2 (2.43±0.56), (2.38±0.43) h, tmax(2.67±0.82), (2.74±0.80) h, cmax (63.37±15.36), (64.07±14.43) ng/mL,AUC (130.36±15.20), (128.47±20.87) ng/(h·mL) respectively. The relative bioavailability of the test capsule was (101.5±6.3)%. [Conclusion] The results demonstrate that the two capsules are bioequivalent.
Key concepts: Bioequivalence, Flunarizine, Bioavailability, Cmax, Capsule, Pharmacokinetics, Pharmacology, Medicine